The Motley Fool

Two bargain dividend stocks that should provide an income for life

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

With the UK population forecast to grow over the coming years, demand for housing is expected to increase significantly. Furthermore, the population is also ageing, and demand for retirement housing is also expected to rise. Similarly, spending on healthcare may also gradually increase for people of all ages in the long run. As such, investing in those types of industries could prove to be worthwhile. Here are two dividend stocks which may therefore be worth buying right now.

A difficult period

Reporting on Wednesday was retirement housebuilder McCarthy & Stone (LSE: MCS). Its half-year results showed that it faced a difficult start to the year, with trading constrained by the lower forward order book brought into the year. This resulted from the market uncertainty following the EU referendum, as well as the anticipated weighting of legal completions from higher margin sites into the second half of the year and the lower number of sales releases during the period.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic… and with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times.

Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…

We’re sharing the names in a special FREE investing report that you can download today. And if you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio.

Click here to claim your free copy now!

As such, McCarthy & Stone’s revenue declined by 5% and its operating profit moved 23% lower. However, its future performance is expected to be significantly better. It is forecast to record a rise in earnings of 13% in the current year, followed by further growth of 27% next year. This shows that the long-term trend within the industry is positive, and also that the company’s current strategy is working well.

Despite this, McCarthy & Stone trades on a price-to-earnings growth (PEG) ratio of just 0.3. This indicates it offers a wide margin of safety, as well as capital growth potential. With a dividend yield of 2.7%, it may lack income appeal today. However, with dividends covered 3.2 times by profit and forecast to rise by 27% next year, it could quickly become a must-have income share for the long run.

Growth potential

Also offering dividend growth potential is social care company CareTech (LSE: CTH). It looks set to experience rising demand for its services as spending on healthcare continues to increase. Therefore, while its performance in the short run may be somewhat mixed, in future years it could prove to be a relatively solid growth play.

As with McCarthy & Stone, CareTech has a relatively low valuation. It trades on a price-to-earnings (P/E) ratio of just 10.6, which indicates that a wide margin of safety is on offer. And with growth in its bottom line forecast for next year, a gradual rise in its share price could be warranted.

With a dividend yield of 2.6%, CareTech may not be one of the highest-yielding shares around at the present time. However, with dividends covered 3.6 times by profit, the company should be able to raise shareholder payouts at a rapid rate without hurting its long-term growth potential. Its bottom line growth should also mean dividends can be moved higher, which could make it a strong income stock for the long term.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.